# Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis

> **NCT02111018** · PHASE2 · WITHDRAWN · sponsor: **CytoSorbents, Inc**

## Conditions studied

- Rhabdomyolysis

## Interventions

- **DEVICE:** CytoSorb Device
- **PROCEDURE:** CVVH

## Key facts

- **NCT ID:** NCT02111018
- **Lead sponsor:** CytoSorbents, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-03
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2023-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02111018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02111018, "Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02111018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*